Atlas Trials

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Clinical trial NCT00742339 · TERMINATED

Trial details

NCT number
NCT00742339
Sponsor
University of Padova
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
CirrhosisHepatorenal Syndrome
Start date
2005-05-01
Primary completion
2013-10-01
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.